-+ 0.00%
-+ 0.00%
-+ 0.00%

Maze Therapeutics President R&D, CMO Harold Bernstein sells common shares worth $393,354

PUBT·05/18/2026 21:04:21
Listen to the news
Maze Therapeutics President R&D, CMO Harold Bernstein sells common shares worth $393,354
  • Maze Therapeutics President, R&D and CMO Harold Bernstein exercised stock options for 15,000 shares at USD 10.42 on May 14.
  • Bernstein sold 15,000 shares the same day at a weighted average price of USD 26.22, leaving him with no directly held common stock.
  • He reported beneficial ownership of 222,407 stock options following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002050172-26-000021), on May 18, 2026, and is solely responsible for the information contained therein.